Staff Report
The infection control market is projected to register a CAGR of 6.5% during the forecast period (2021-2026), according to Mordor Intelligence.
The infection control market is primarily driven by the high prevalence of nosocomial infections and the growing number of surgeries that require control measures to stop spreading, a Mordor Intelligence summary report states. According to the Centers for Disease Control and Prevention (CDC), about one in every 20 patients admitted for treatment will develop a nosocomial infection. Hospital-acquired infections result in more than 99,000 deaths each year. The lack of awareness regarding infection control and stringent regulatory requirements are anticipated to impede market growth. However, the government and non-government organizations’ initiatives regarding infection control, coupled with the growing control measures by the health care providers in hospitals, are expected to drive the market growth. For instance, in January 2020, The Ministry of Health and Population has launched the second phase of infection control initiatives in nine governorates of Egypt.
Sterilization is important to control infectious diseases that may exist everywhere in hospitals or health care facilities, and it is debatable whether antibiotics can control such an extensive attack.
The sterilization products and services segment under the product and services segment is anticipated to have lucrative growth owing to the increasing need to reduce hospital-acquired infection and extensive use of sterilization equipment in the health care settings. According to the World Health Organization (WHO), at least 30 new diseases emerged in the last 20 years, and infectious diseases kill 17 million people every year.
Moreover, an increasing number of surgeries, increasing prevalence of infectious diseases and growth in the health care industry are anticipated to boost the market growth over the forecast period.
In the end-user segments, the hospital is anticipated to have a significant growth due to the increasing adoption of infection control products due to increasing number of patients suffering from COVID-19 and stringent regulations by the respective governments to control the infections.
North America is anticipated to have significant growth owing to well-established health care infrastructure, high adoption of infection control technologies and the presence of the key market players in the region. Furthermore, the initiatives are taken by the government authorities in infection control and recent product launches. For instance, Getinge AB has launched a new 9100E Cart Washer in the United States for the health care industry.
On the other hand, the Asia Pacific region is anticipated to have lucrative market growth due to the growing health care industry, increasing disposable income and expanding health care providers’ investments in infection control. Moreover, infection control initiatives and the growing number of hospital-acquired infections in the region are anticipated to boost the market growth over the forecast period.
The global infection control market is moderately fragmented and competitive. Market players are focusing on new product launches, product innovations and geographical expansion to strengthen its market share.
Global Market Insights (GMI) is another research firm that predicts market growth.
“Infection control supplies market size was worth over $34 billion in 2022. Driven by the rising incidence of chronic ailments globally, the industry could grow at over 6% CAGR from 2023 to 2032,” according to GMI.
